openPR Logo
Press release

Antacids Market to soar with CAGR of ~4% by 2025

03-15-2021 10:40 AM CET | Health & Medicine

Press release from: Fact.MR

Antacids Market

Antacids Market

Online pharmacies will grow as a prominent sales channel in the antacids market. A marked rise in the popularity of this channel is attributable to consumer-centric deals, such as attractive discounts and home delivery services. There is no permanent panacea for acid reflux and heartburn, which inadvertently is expected to retain consumers’ reliance on antacids.

This Press Release will help you to understand the market Statistics of European Region.

Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) at @ https://www.factmr.com/connectus/sample?flag=S&rep_id=4328

The sustained rise in the demand for these drugs is encouraging manufacturers to take the research route to introduce effective novel drugs. Market players are disseminating information about the drug launch through the conduction of strategic marketing campaigns to boost their brand recognition. The relevance of these trends, along with futuristic ones, have been assessed in an extensive report published by Fact.MR. Authors of the report portend that, the antacids market will expand at an average CAGR of ~4% during the forecast period (2020-2025).

Key Highlights of Antacids Market Study

• Consumers’ inclination towards antacid tablets as a preferable formulation is projected to remain high, estimated to account for ~70% of the total share in the antacids market by 2025. Efforts made by manufacturers towards the development of chewable and flavored tablets will increase the demand for tablets during 2020-2025.
• Growing popularity of the self-medication trend and over-the-counter (OTC) availability of antacids are expected to unlock sales streams such as hospital pharmacies and retail pharmacies. Among these channels, retail pharmacies will account for one-third of the total sales generated by 2025.

For information on the Research Approach used in the Report, Ask for Methodology @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=4328

• Sedentary lifestyles of consumers are leading to numerous cases of heartburn and acidity, given the long work hours and consumption of ready-to-eat meals with high preservatives. This is increasing consumers’ reliance on digestive remedies, and, in turn, thrusting the growth of the antacids market.
• In 2020, Proton Pump Inhibitors are projected to account for ~67% of the total market share, as these are widely acceptable drug classes for treatment of acid reflux. However, increasing information about the negative profile of these drugs is boosting the sales of H2 Antagonist.

Drug-induced Heartburn to Unfold New Growth Tangents for Market Players

The fragmented antacids market is attracting new entrants, owing to the easy availability of raw materials and low overhead costs. The possibilities of backward integration are extremely remote in the antacids market, given the high concentration of suppliers and low prices of raw materials. This instigates market players to position their brands with effective pricing and product differentiation strategies. Relaxed regulations for over-the-counter drugs have been supporting the distribution efforts of market players by increasing the penetration of antacids through online and offline sales channels.

Full Access of this Exclusive Report is Available at @ https://www.factmr.com/checkout/4328/S

Medications such as calcium channel blockers and beta blockers that are meant to relieve blood pressure increase stomach acid, which aggravates heartburn. In addition, bone-strengthening drugs such as bisphosphonates, risedronate, alendronate, and ibandronate that are consumed to treat osteoporosis lead to heartburn. These drugs, are, in turn, increasing the reliance of blood pressure patients on antacids.

In this intensely-competitive antacids market, besides research & development activities, distribution partnerships will bring in long-term growth opportunities.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/4328/antacids-market
Content Source: https://www.factmr.com/media-release/1154/global-antacids-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antacids Market to soar with CAGR of ~4% by 2025 here

News-ID: 2256266 • Views:

More Releases from Fact.MR

U.S. Population Health Management (PHM) Solutions Market Set to Hit US$ 34.59 Billion by 2028 | Fact.MR
04-19-2024 | Health & Medicine
Fact.MR
U.S. Population Health Management (PHM) Solutions Market Set to Hit US$ 34.59 Bi …
The global market for population health management (PHM) solutions in the United States is expected to expand at a compound annual growth rate (CAGR) of 14.8% between 2021 and 2028, according to a recently released Fact.MR analysis. By the end of 2028, the market is projected to reach US$ 34.59 billion. Over the projected period, there is anticipated to be an increase in demand for U.S. Population Health Management (PHM)
Bleaching Clay Market is Anticipated to Grow at a CAGR of 7.2% to Top US$ 1.86 Billion by 2032
Bleaching Clay Market is Anticipated to Grow at a CAGR of 7.2% to Top US$ 1.86 B …
The bleaching clay market was valued at US$ 932.2 million in 2022. Moreover, growth is anticipated to pick up speed at a robust 7.2% CAGR during the evaluation period of 2022-2032, culminating in US$ 1.86 billion. Bleaching clay has been widely utilized for edible oil purification since the nineteenth century. Variations in the yield of oilseed crops are anticipated to positively affect the global market for bleaching clay since bleaching
Automated Microscopy Market to Reach US$ 8.5 Billion by 2027, Grow at a CAGR of 7.5%: Fact.MR
04-19-2024 | Health & Medicine
Fact.MR
Automated Microscopy Market to Reach US$ 8.5 Billion by 2027, Grow at a CAGR of …
According to the most recent analysis conducted by market research and competitive intelligence company Fact.MR, the automated microscopy market is expected to be valued US$ 8.5 billion globally by 2027. With the use of sophisticated monitoring techniques, automated microscopy is a contemporary technology that enhances the monitoring of biological material. In addition to reducing human error, automated microscopy offers accurate, automated magnification for topic examination and analysis. Because automated microscopy is
Toy Drone Market Trends: CAGR of 8.6% Propels Growth to US$ 951.5 Million by 2033
Toy Drone Market Trends: CAGR of 8.6% Propels Growth to US$ 951.5 Million by 203 …
It is Anticipated That the Toy Drone Market Will Reach US$ 951.5 Million by 2033 At A CAGR of 8.6% | Fact.MR growing Children's Propensity for Playing with Drones for Recreation Will Support Market Expansion the global toy drone market is anticipated to reach US$ 417 million in 2023 and develop at a compound annual growth rate (CAGR) of 8.6% over the forecast period of 2023-2033, according to Fact.MR. Because

All 5 Releases


More Releases for Antacids

Antacids Market Analysis by Key Players & Industry Size 2027
Allied Market Research published a report, titled, “Antacids Market: Global Opportunity Analysis and Industry Forecast 2019–2027". According to the report, the Global Antacids industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027. Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10646 Major players analyzed include GlaxoSmithKline plc, Pfizer Inc, Bayer AG, Dr. Reddy's Laboratories Ltd, AstraZeneca PLC, Boehringer
Antacids Market Companies Overview 2017 - 2025
The global antacids market features a large number of companies, both international as well as regional, which serve the global market through a large number of products varieties and brands. The level of competition is thus intense and the high focus of companies on new markets and growth opportunities is evident through the several strategic collaborations to have taken place in the market in the past years, observes Transparency Market
Antacids Market Overview and Industry Outlook 2020
Global Antacids Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Antacids Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected
Antacids Market will Clock a 3.7% CAGR Between 2017 and 2025
The worldwide antacids market is a choc-o-bloc with large companies that hold prominence due to their product offerings and presence across geographies, observes Transparency Market Research (TMR). R&D initiatives for the introduction of novel therapies, improving efficacy of existing drugs are the focus of key players in this market to gain competitive advantage. These players are also seeking strategic partnerships and business alliances to strengthen their research expertise as well
Global Antacids Market to Surpass US$18.7 bn by 2025
With a large pool of established players such as AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble, Reckitt Benckiser Group plc, Sanofi, Sun Pharmaceuticals Ltd., Takeda Pharmaceutical Company Ltd., and Valeant Pharmaceuticals International Inc., the worldwide antacids market features a competitive and a fragmented vendor landscape, notes a research report by Transparency Market Research (TMR). Development of novel therapies
Antacids Market to Witness an Outstanding Growth by 2025
With a large pool of established players such as AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble, Reckitt Benckiser Group plc, Sanofi, Sun Pharmaceuticals Ltd., Takeda Pharmaceutical Company Ltd., and Valeant Pharmaceuticals International Inc., the worldwide antacids market features a competitive and a fragmented vendor landscape, notes a research report by Transparency Market Research (TMR). Development of novel therapies